Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer
Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Cevimeline may be effective in treating dry mouth that is caused by radiation
therapy for head and neck cancer. It is not yet known if cevimeline is more effective than no
therapy in treating dry mouth caused by radiation therapy.
PURPOSE: Randomized phase III trial to determine the effectiveness of cevimeline in treating
patients who have dryness of the mouth caused by radiation therapy for head and neck cancer.